Published in Pharmacol Rep on January 01, 2012
Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive review. Biomed Res Int (2014) 0.80
The Role of Topiramate in the Management of Cocaine Addiction: a Possible Therapeutic Option. Curr Neuropharmacol (2015) 0.75
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig Liver Dis (2012) 1.55
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol (2009) 1.50
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci (2012) 1.47
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Adverse effects of atypical antipsychotics in the elderly: a review. Drugs Aging (2006) 1.15
Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol (2003) 1.13
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia (2009) 1.11
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma. Respir Med (2008) 1.07
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. J Med Chem (2006) 1.06
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
Mitogen-activated protein kinases and asthma. J Cell Physiol (2005) 1.04
Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology (2013) 1.03
Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res (2013) 1.03
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Neuropharmacology (2012) 1.03
Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology (2004) 1.01
Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf (2009) 0.99
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia (2010) 0.99
Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin. Wound Repair Regen (2013) 0.97
Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. Adv Pharmacol Sci (2013) 0.96
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology (2005) 0.96
The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol Neurobiol (2012) 0.95
Lack of efficacy during the switch from brand to generic allopurinol. J Forensic Leg Med (2013) 0.92
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention. Updates Surg (2012) 0.92
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia (2011) 0.91
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology (2012) 0.91
Off-label prescribing patterns of antiemetics in children: a multicenter study in Italy. Eur J Pediatr (2012) 0.89
Doxycycline speeds up healing of chronic venous ulcers. Int Wound J (2013) 0.89
Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts. J Cell Physiol (2007) 0.89
Asterixis as a presentation of cerebellar ischemic stroke. West J Emerg Med (2012) 0.88
Solution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents. Chem Pharm Bull (Tokyo) (2008) 0.88
Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol (2014) 0.88
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol (2004) 0.87
Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation. Ann Pharmacother (2008) 0.87
Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells. J Cell Biochem (2004) 0.87
Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management. Curr Neuropharmacol (2012) 0.86
Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy. Ann Pharmacother (2010) 0.86
Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol (2014) 0.86
Respiratory infections and asthma. Respir Med (2005) 0.86
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. Medicine (Baltimore) (2016) 0.86
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res (2011) 0.85
Rosacea-like facial rash related to metformin administration in a young woman. BMC Pharmacol Toxicol (2014) 0.85
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide. BMC Pharmacol Toxicol (2014) 0.85
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology (2012) 0.85
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. Eur J Neurosci (2009) 0.85
Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in a rare case of multiple artery aneurysm. Ann Vasc Surg (2013) 0.85
Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects. Basic Clin Pharmacol Toxicol (2004) 0.85
Pain management for dentists: the role of ibuprofen. Ann Stomatol (Roma) (2012) 0.85
Neuropharmacology of depression in aging and age-related diseases. Ageing Res Rev (2002) 0.84
Spinal myoclonus responsive to topiramate. Mov Disord (2004) 0.84
Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman. J Clin Pharmacol (2013) 0.84
Effects of ethanol on the development of genetically determined epilepsies in rats. Int J Dev Neurosci (2008) 0.83
Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus. Expert Rev Anti Infect Ther (2015) 0.83
Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium. Headache (2013) 0.83
Update on optimal use of omalizumab in management of asthma. J Asthma Allergy (2011) 0.83
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. Curr Drug Saf (2009) 0.83
Use of topiramate for glossodynia. Pain Med (2007) 0.83
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res (2012) 0.83
Metalloproteinase-9 and neutrophil gelatinase-associated lipocalin plasma and tissue levels evaluation in middle cerebral artery aneurysms. Br J Neurosurg (2014) 0.82
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. J Med Chem (2003) 0.81
Activation of the nociceptin/orphanin FQ receptor reduces bronchoconstriction and microvascular leakage in a rabbit model of gastroesophageal reflux. Br J Pharmacol (2005) 0.81
Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman. Clin Drug Investig (2004) 0.81
A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations. BioDrugs (2014) 0.81
A review on antiepileptic drugs-dependent fatigue: pathophysiological mechanisms and incidence. Eur J Pharmacol (2013) 0.81
Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res (2005) 0.81
A questionnaire-based study on prevalence and treatment of headache in young children. J Headache Pain (2005) 0.80
Anti-inflammatory Strategies in Stroke: a Potential Therapeutic Target. Curr Vasc Pharmacol (2016) 0.80
The safety of clozapine in the elderly. Expert Opin Drug Saf (2008) 0.80
Capecitabine-induced, rapid decrease of renal function due to drug dispensing error in a hospital pharmacy. J Clin Pharmacol (2010) 0.80
Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res (2015) 0.80
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology (2006) 0.80
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav Brain Res (2011) 0.80
Effects of carbamazepine/oxycodone coadministration in the treatment of trigeminal neuralgia. Ann Pharmacother (2011) 0.80
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease. Eur J Neurosci (2009) 0.80
Melaena following Use of the Cholinesterase Inhibitor Rivastigmine. Clin Drug Investig (2005) 0.79
Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review. Autoimmunity (2014) 0.79
New AMPA antagonists in epilepsy. Expert Opin Investig Drugs (2012) 0.79
Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy. J Neurochem (2008) 0.79